Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lyell Immunopharma
Lyell Immunopharma
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate
BioSpace
Wed, 06/26/24 - 10:07 am
Lyell Immunopharma
clinical trials
CAR-T
LYL797
patient deaths
No regrets as Lyell prepares for its first clinical trial
EP Vantage
Mon, 02/7/22 - 11:13 am
Lyell Immunopharma
IPOs
clinical trials
cell therapy
cancer
oncology
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
Fri, 12/31/21 - 11:04 am
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
Another four IPOs complete busy week as biotech raise continues to match 2020's record pace
Endpoints
Fri, 06/18/21 - 10:06 am
IPOs
Lyell Immunopharma
Verve Therapeutics
Molecular Partners
ATAI Life Sciences
Century Therapeutics
Ambrx
Cyteir Therapeutics
GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO
Fierce Biotech
Wed, 05/26/21 - 11:16 am
Lyell Immunopharma
GSK
IPOs
funding
solid tumors
Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors
Fierce Biotech
Wed, 09/2/20 - 11:13 am
Orca Bio
Lyell Immunopharma
R&D
solid tumors
cell therapy